Cargando…

Angiopoietin-like protein 4 and cardiovascular function in COPD

INTRODUCTION: The coexistence of chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) is frequent and might be inter-related through inflammation-related processes reflected by specific markers. Here, we studied angiopoietin-like protein 4 (ANGPTL4), an upcoming cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waschki, B, Kirsten, AM, Holz, O, Meyer, T, Lichtinghagen, R, Rabe, KF, Magnussen, H, Welte, T, Watz, H, Janciauskiene, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133419/ https://www.ncbi.nlm.nih.gov/pubmed/27933182 http://dx.doi.org/10.1136/bmjresp-2016-000161

Ejemplares similares

Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis
por: Fermont, Jilles M, et al.
Publicado: (2019)

FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease
por: Alderawi, Amr, et al.
Publicado: (2020)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD
por: Faiz, Alen, et al.
Publicado: (2023)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD
por: Grosbois, Jean-Marie, et al.
Publicado: (2022)

Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD
por: Garratt, Andrew Malcolm, et al.
Publicado: (2022)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
por: Moll, Matthew, et al.
Publicado: (2020)

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
por: Marcon, Alessandro, et al.
Publicado: (2018)

Environmental triggers of COPD symptoms: a case cross-over study
por: Sama, Susan R, et al.
Publicado: (2017)

Adjuncts for sputum clearance in COPD: clinical consensus versus actual use
por: Barker, Ruth, et al.
Publicado: (2017)

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study
por: Hansel, Nadia N, et al.
Publicado: (2017)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Prevalence and burden of COPD misclassification in the Canadian Longitudinal Study on Aging (CLSA)
por: Farooqi, M A Malik, et al.
Publicado: (2022)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51i8quhv9gh4olp4jju1mn1r07